← SynDRA
NUMIDARGISTAT
SynDRA canonical compound SYN0039337 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | ARG1 | ARG2 | IFNLR1 |
|---|
| Mechanism of action | arginase inhibitor |
|---|
| Indication | bladder cancer |
|---|
| Disease area | oncology |
|---|
All known targets
- ARG1
- ARG1; ARG2
- ARG2
- IFNLR1
Mechanisms of action (all sources)
- arginase inhibitor
- Inhibitor
Drug classes
Cross-references
Synonyms
- Arginase inhibitor incb001158
- INCB-001158
- INCB001158
- CB-1158
- INCB01158
- CB 1158
- Incb 001158
- Arginase inhibitor INCB001158
- IFD73D535A
- CB1158
- RefChem:166961
- Numidargistat [USAN]
- UNII-IFD73D535A
- WHO 11086
- numidargistatum
- CB-1158 dihydrochloride
- NUMIDARGISTAT [INN]
- Numidargistat (USAN/INN)
- INCB-01158 dihydrochloride
- NUMIDARGISTAT [WHO-DD]
- orb1710146
- CB1158, 2HCl
- SCHEMBL18787950
- CB-1158, 2HCl
- CHEBI:195556
- EX-A2679
- BDBM50511658
- NSC803247
- AKOS040732725
- CS-8064
- NSC-803247
- T10692L
- NCGC00600721-01
- DA-51640
- HY-101979
- D11792
- G16257
- CB-1158 diHCl
- CB-1158 dihydrochloride;INCB01158 dihydrochloride
Look up NUMIDARGISTAT in the interactive SynDRA portal →